Douglass Hochstetler serves as lead counsel in patent infringement matters, especially in litigation arising under the Hatch-Waxman Act. Selected as one of The Best Lawyers in America© in Patent Law & Litigation; an “IP Star” by Managing Intellectual Property magazine, a “Super Lawyer” and a “Leading Lawyer” in Intellectual Property Law by Illinois Leading Lawyers Network, he has represented generic drug companies in Hatch-Waxman matters for the last 20 years.
Prior to being a partner in a large law firm and IP boutique firm since 1990, Doug served as an associate at an IP boutique firm from 1985 to 1990, served in legal and business positions at a large chemical company from 1977 to 1985, and clerked for a Crystal City patent firm and the U.S. Department of Justice while in law school.
Abbott Laboratories v. Mylan Inc.
(N.D. Ill) (lopinavir/ritonavir)
Abbott Laboratories v. Novartis Nutrition
(N.D. Ill) (nutritional supplement)
AHP v. Upjohn Co.
(D.N.J.) (canine vaccine)
AstraZeneca Pharmaceuticals LP v. Sandoz, Inc
. (D.N.J. and Fed. Cir.) (quetiapine)
AstraZeneca LP v. Lek Pharmaceuticals
AstraZeneca Pharmaceuticals LP v. Lupin Pharmaceuticals
Cephalon, Inc. v. Sandoz, Inc
. (D.N.J.) (modafinil)
Elan v. Corepharma
Endo Pharm. v. Perrigo Co.
(D. Del.) (testosterone)
Forest Laboratories v. Lupin Pharmaceuticals
(D. Del.) (memantine)
Forest Laboratories, LLC v. Lupin Ltd
(D.N.J.) (memantine hydrochloride)
G.D. Searle LLC v. Lupin Pharmaceuticals, Inc.
(E.D.Va. and Fed. Cir.) (celecoxib)
Jordan v. Isuzu Motors
(N.D. Ill.) (automobile component)
LAB, SA v. Chemithon Corporation
. (W.D. Wash.) (electrostatic precipitation equipment)
McNeil-PPC v. Procter & Gamble
(D. Colo.) (sanitary products)
Orexo v. Mylan
Organon Pharmaceuticals v. Geneva Pharmaceuticals
Oscar Mayer v. Sara Lee
(W.D. Wisc.) (package design)
Otsuka Pharmaceutical Co., Ltd. v. Lupin Ltd.
Pfizer, Inc. v. Geneva Pharmaceuticals
Pfizer, Inc. v. Sandoz, Inc
. (D. Del.) (azithromycin)
Proctor & Gamble v. Kimberly-Clark
(D.S.C.) (disposable diapers)
RCT v. Ben Venue Laboratories
Sanofi v. Sandoz, Inc.
(D.N.J. and Fed. Cir.) (oxaliplatin)
Schering-Plough v. Geneva Pharmaceuticals
(D.N.J. and Fed. Cir.) (loratadine)
Sciele Pharma, Inc. v. Lupin Pharmaceuticals (D. Del. and Fed. Cir.) (metformin)
Sepracor, Inc. v. Lupin Pharmaceuticals
LLC v. CorePharma, LLC
(D.N.J.) (mixed amphetamine salts)
Shire Pharmaceuticals v. Mylan Inc.
(S.D.N.Y.) (lanthanum carbonate)
Taro Pharmaceuticals v. Synerx Pharma
, LLC (D.N.J.) (malathion lotion)
Teva Women’s Health v. Lupin Pharmaceuticals, Inc., et al.
(D.N.J.) (oral contraceptives)
Transco Prods. v. PCI
(Fed. Cir.) (nuclear reactor insulation)
UCB, Inc. v. CorePharma, LLC
Unigen Pharmaceuticals v. Perrigo Company, et al.
(W.D. Wash.) (antioxidant product)
United States Gypsum v. National Gypsum
(N.D. Ill. and Fed. Cir.) (lightweight joint compound)
Warner Chilcott v. Lupin Pharmaceuticals
(D. Del.) (oral contraceptives)